Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > More now, than before Trogarzo FDA nod
View:
Post by FredTheVoice on Jan 21, 2021 10:37am

More now, than before Trogarzo FDA nod

I bought more this morning,

I am more invested now in TH than before approval of Trogarzo.

Confidence, despite general bashing (market, and reaction after financing), is in my view higher today with two studies who will create lots of excitment around this company.

In a year or so, and maybe much faster with the oncology study, I think no one will be thinking about the january 2021 financing. With the attention around the financing, we all forgot that sales are gaining momentum......

GLTA.

FTV.
Comment by Bucknelly21 on Jan 21, 2021 10:50am
Geez it's January and we are already talking about next year. There nothing ever right in front of us it's always couple months out, or q3, or next year. We are always saying that because management doesn't know how to provide value for shareholders 
Comment by SPCEO1 on Jan 21, 2021 11:51am
It amkes a lot of sense that you have more TH stock now than before Trogarzo because Trogarzo was a big deal for TH but a not a huge potential market. In both NASH and cancer, we have huge potential markets. Both are markets that are of great interest to Pfizer or Lilly or any of the big pharma companies. Now, because of that, there is a lot more competition to be dealt with in NASH and cancer and ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse